Medical Condition News

RSS

Kyto Biopharma enters agreement with Targeted Payload Therapeutics

Kyto Biopharma Inc., is a Florida biotechnology company focused on developing monoclonal antibody and oligonucleotide targeting therapeutics based on a proprietary vitamin B12 platform for the treatment of various forms of cancer.

3 Apr 2010

Changes in self-esteem over time

Self-esteem rises steadily as people age but starts declining around the time of retirement, according to a longitudinal study of men and women ranging in age from 25 to 104.

3 Apr 2010

Fireside chat: BioSante's LibiGel and GVAX cancer vaccines portfolio

BioSante Pharmaceuticals, Inc. today announced that a BioSante presentation and corporate discussion are available at http://www.rodm.tv/video1269553400.

3 Apr 2010

Therapeutic hypothermia helps save marathon cardiac arrest victim

Jay Yim, 21, had worked on improving his fitness since age 15. In preparation for this year's Los Angeles Marathon on March 21, the University of Southern California pre-med student had been training with a marathon club and regularly did 10-mile runs on his own.

3 Apr 2010

Detroit cancer center to conduct free oral, head and neck cancer screenings

On Friday, April 16, from 2 - 5 p.m., the Barbara Ann Karmanos Cancer Center in Detroit will be conducting free oral, head and neck cancer screenings in conjunction with National Oral Head and Neck Cancer Awareness Week (April 12 – 18.) Some of the symptoms of oral cancer go unnoticed. A simple 10-minute screening exam can determine if there are problems and can help diagnose this disease in its early stage.

3 Apr 2010

Identification and elimination of cancer stem cells

A new field of cancer research could explain why some cancers that appear to have been cured can rear their ugly head or spread to other organs.

3 Apr 2010

Cancer research at Georgia Tech: Report

Cancer treatment typically involves surgery, radiation therapy, chemotherapy, hormone therapy or biological therapy. An oncologist may use one therapy or a combination of methods, depending on the type and location of the cancer, whether the disease has spread, the patient's age and general health, and other factors.

3 Apr 2010

Study: Trial vaccine eliminates residual cancer cells in CML patients

Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).

3 Apr 2010

New guidelines will make it easier to evaluate the cost of visual impairment studies

New guidelines that outline best practices for measuring the economic burden of visual impairment will make it easier for the policy, science and medical communities to draw conclusions and compare results across studies.

3 Apr 2010

Notch pathway may be a good target for drug development, study says

Working with mice, Johns Hopkins scientists who tested drugs intended to halt growth of brain cancer stem cells -- a small population of cells within tumors that perpetuate cancer growth -- conclude that blocking these cells may be somewhat effective, but more than one targeted drug attack may be needed to get the job done.

3 Apr 2010

Study could aid in developing new, effective treatments for prostate cancer

Van Andel Research Institute (VARI) scientists have determined how two proteins required for the initiation and development of prostate cancer interact at the molecular level, which could lead to improved treatments for the disease.

3 Apr 2010

RPCI researcher receives grant to explore link between race and breast cancer

Christine Ambrosone, MD, Chair of Cancer Prevention and Control at Roswell Park Cancer Institute (RPCI), has received a grant for $165,000 from the Breast Cancer Research Foundation to study the possible link between race and the possibility of being diagnosed with aggressive breast cancers.

3 Apr 2010

Study uses hESC to derive floor plate tissue

New York Stem Cell Foundation (NYSCF) Fellow, Christopher Fasano, PhD, of the New York Neural Stem Cell Institute, is lead author on a study that investigating human neural development. Dr. Fasano conducted this work while working as a post-doctoral fellow at Memorial Sloan Kettering Cancer Center in the lab of Dr. Lorenz Studer.

3 Apr 2010

A detailed review for managing solid pseudopapillary tumors

Solid pseudopapillary tumor (SPT) of the pancreas is a rare neoplasm with a low malignant potential, usually affecting young women in the second or third decade of life.

3 Apr 2010

Kinetics of T cell receptors: New findings could lead to reevaluation of earlier conclusions

T cell receptors are among the most important molecules in the immune system because of their role in recognizing the antigens that signal such threats as viruses and cancer. The receptors must also distinguish these threats from the body's own cells to avoid triggering an unwanted immune system response.

3 Apr 2010

Ultrasound and light for determining tumor's response to therapy in early stages

A biomedical scientist at Ryerson University in Toronto, Canada is exploring how ultrasound and light can be used to measure the effectiveness of cancer treatment in the early stages of therapy. By comparing high-frequency ultrasound patterns before and after treatment, doctors can potentially know within days if a tumor is responding to a prescribed therapy.

3 Apr 2010

APHON calls for improved treatment and care for young cancer patients

"Pediatric oncology teams across the county are working every day to improve the care for adolescents and young adults (AYAs) with cancer," said Deborah Echtenkamp MSN RN CPON®, president of the Association of Pediatric Hematology/Oncology Nurses (APHON). "But there is more to be done, both for AYA care and to support survivorship programs that monitor patients following treatment for childhood cancer."

3 Apr 2010

NEDA and Alliance panel explore ways to reduce negative effects of obesity and eating disorders

The television news and entertainment media are missing the mark when it comes to communicating realistic and helpful information about health and weight to Americans, according to an expert media panel assembled today at Pace University in New York City.

3 Apr 2010

New production method yields hundredsfold more ubiquitylated proteins critical for cancer research

Scientists at the University of Delaware have developed a new method for producing proteins critical to research on cancer, Alzheimer's, and other diseases.

3 Apr 2010

Lyric invisible extended wear hearing device helps judo olympian hear opponent's breathing

When Grace Jividen competed in the 1992 Olympics in Barcelona, Spain, she couldn't hear her opponent's breathing, which she believes could have given her the edge in her judo competitions. Now, the former member of the 1992 U.S. women's judo team and holder of more than 41 medals from international competitions and a sixth degree black belt has the edge she was looking for thanks to Lyric, the world's first 100 percent invisible extended wear hearing device.

3 Apr 2010